Skip to main content
. 2008 Feb 19;98(6):1053–1058. doi: 10.1038/sj.bjc.6604273

Figure 2.

Figure 2

Kaplan–Meier charts demonstrating patient survival from the date of first 131I-MIBG treatment for (A) symptomatic, (B) radiological and (C) biochemical variables comparing responders to 131I-MIBG therapy with non-responders.